Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores

Abstract

Get full access to this article

View all access options for this article.

References

Lip

GYH

Freedman

de Caterina

, et al. Stroke prevention in atrial fibrillation: past, present and future comparing the guidelines and practical decision-making. Thromb Haemost 2017; 117: 1230–1239.

Proietti

Lane

Boriani

, et al. Stroke prevention, evaluation of bleeding risk, and anticoagulant treatment management in atrial fibrillation contemporary international guidelines. Can J Cardiol 2019; 35: 619–633.

Boriani

Proietti

Laroche

, et al. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry. Europace 2018; 20: 747–757.

O’Brien

Holmes

Ansell

, et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 2014; 167: 601–609.e1.

Gamble

Buono

Mamas

, et al.

Does prior antithrombotic therapy influence recurrence and bleeding risk in stroke patients with atrial fibrillation or atrial flutter?

Eur J Prev Cardiol. 2020; 27: 729–737.

Lip

GYH

Laroche

Popescu

, et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Europace 2015; 17: 1777–1786.

Proietti

Nobili

Raparelli

, et al. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. Clin Res Cardiol 2016; 105: 912–920.

Rivera-Caravaca

Roldán

Esteve-Pastor

, et al. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost 2017; 117: 1448–1454.

Boriani

Proietti

. Atrial fibrillation prevention: an appraisal of current evidence. Heart 2018; 104: 882–887.

10.

Di Benedetto

Michels

Luben

, et al. Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: the EPIC-Norfolk prospective population study. Eur J Prev Cardiol 2018; 25: 1374–1383.

11.

Aune

Schlesinger

Norat

, et al. Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018; 25: 1437–1451.